http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1224530-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8e49a2b5f6d0ba32839687472b3a437
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-22
filingDate 1968-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1971-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1224530-A
titleOfInvention Indolyltetrahydropyridines
abstract 1,224,530. Indolyl - pyridine derivatives. MILES LABORATORIES Inc. 31 Dec., 1968 [15 Jan., 1968], No. 61988/68. Heading C2C. Novel compounds I in which R is H or 1-4 C alkyl; R<SP>1</SP> is H, 1-4 C alkyl, aralkyl, substituted aralkyl, or aroyl; and R<SP>2</SP> is H, 1-4 C alkoxy or OH and dimers or salts thereof are prepared by reduction of a compound II, where R<SP>1</SP> is not aroyl followed where necessary by reaction with a Grignard reagent and an aroyl halide to give I where R<SP>1</SP> is aroyl and/or salt formation. Compounds II are prepared by cyclization of compounds III followed by reaction with RX where X is halo. Compounds III are prepared by reaction of 3-acetyl-pyridine with the appropriate hydrazine. Pharmaceutical compositions for oral or parenteral administration as antihistamine or antiserotonin agents comprise a compound I together with a suitable carrier.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8030334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8791141-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009156462-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009156462-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0071520-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9242963-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102076665-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-018731-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2486081-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0021924-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0021924-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2510111-A1
priorityDate 1968-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID270302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411301727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411942053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69525512

Total number of triples: 31.